全文获取类型
收费全文 | 1165篇 |
免费 | 76篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 53篇 |
妇产科学 | 12篇 |
基础医学 | 222篇 |
口腔科学 | 87篇 |
临床医学 | 106篇 |
内科学 | 291篇 |
皮肤病学 | 3篇 |
神经病学 | 54篇 |
特种医学 | 67篇 |
外国民族医学 | 2篇 |
外科学 | 107篇 |
综合类 | 10篇 |
预防医学 | 104篇 |
眼科学 | 14篇 |
药学 | 46篇 |
中国医学 | 1篇 |
肿瘤学 | 56篇 |
出版年
2021年 | 8篇 |
2019年 | 17篇 |
2018年 | 17篇 |
2017年 | 11篇 |
2016年 | 14篇 |
2015年 | 12篇 |
2014年 | 12篇 |
2013年 | 15篇 |
2012年 | 31篇 |
2011年 | 42篇 |
2010年 | 28篇 |
2009年 | 26篇 |
2008年 | 40篇 |
2007年 | 56篇 |
2006年 | 36篇 |
2005年 | 40篇 |
2004年 | 45篇 |
2003年 | 32篇 |
2002年 | 38篇 |
2001年 | 25篇 |
2000年 | 28篇 |
1999年 | 26篇 |
1998年 | 22篇 |
1997年 | 22篇 |
1996年 | 14篇 |
1995年 | 14篇 |
1994年 | 19篇 |
1992年 | 30篇 |
1991年 | 42篇 |
1990年 | 15篇 |
1989年 | 26篇 |
1988年 | 27篇 |
1987年 | 40篇 |
1986年 | 26篇 |
1985年 | 34篇 |
1984年 | 25篇 |
1983年 | 17篇 |
1982年 | 11篇 |
1979年 | 8篇 |
1977年 | 10篇 |
1976年 | 13篇 |
1975年 | 9篇 |
1974年 | 11篇 |
1970年 | 16篇 |
1967年 | 9篇 |
1966年 | 10篇 |
1928年 | 7篇 |
1927年 | 8篇 |
1926年 | 14篇 |
1925年 | 12篇 |
排序方式: 共有1241条查询结果,搜索用时 15 毫秒
31.
32.
33.
EG Burden RW Walker DJ Ferguson AMF Goubran JR Howell JB John F Khan JS McGrath JP Evans 《Annals of the Royal College of Surgeons of England》2021,103(3):173
IntroductionWith the emergence of the COVID-19 pandemic, all elective surgery was temporarily suspended in the UK, allowing for diversion of resource to manage the anticipated surge of critically unwell patients. Continuing to deliver time-critical surgical care is important to avoid excess morbidity and mortality from pathologies unrelated to COVID-19. We describe the implementation and short-term surgical outcomes from a system to deliver time-critical elective surgical care to patients during the COVID-19 pandemic.Materials and methodsA protocol for the prioritisation and safe delivery of time-critical surgery at a COVID-19 ‘clean’ site was implemented at the Nuffield Health Exeter Hospital, an independent sector hospital in the southwest of England. Outcomes to 30 days postoperatively were recorded, including unplanned admissions after daycase surgery, readmissions and complications, as well as the incidence of perioperative COVID-19 infection in patients and staff.ResultsA total of 128 surgical procedures were performed during a 31-day period by a range of specialties including breast, plastics, urology, gynaecology, vascular and cardiology. There was one unplanned admission and and two readmissions. Six complications were identified, and all were Clavien-Dindo grade 1 or 2. All 128 patients had preoperative COVID-19 swabs, one of which was positive and the patient had their surgery delayed. Ten patients were tested for COVID-19 postoperatively, with none testing positive.ConclusionThis study has demonstrated the implementation of a safe system for delivery of time-critical elective surgical care at a COVID-19 clean site. Other healthcare providers may benefit from implementation of similar methodology as hospitals plan to restart elective surgery. 相似文献
34.
Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial 总被引:5,自引:0,他引:5
Lanas A Baron JA Sandler RS Horgan K Bolognese J Oxenius B Quan H Watson D Cook TJ Schoen R Burke C Loftus S Niv Y Ridell R Morton D Bresalier R 《Gastroenterology》2007,132(2):490-497
BACKGROUND & AIMS: Our aim was to establish the incidence of symptomatic upper gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) associated with the use of selective cyclooxygenase-2 inhibitors at standard clinical doses compared with placebo. We report here on the PUB outcomes associated with the use of rofecoxib 25 mg in a 3-year, multicenter, double-blind, placebo-controlled trial designed to determine the effect of rofecoxib on the risk of recurrent neoplastic polyps of the colon. METHODS: A total of 2587 patients with a history of colorectal adenomas underwent randomization to 25 mg/day of rofecoxib or to placebo. Investigator-reported PUBs were adjudicated by an external blinded committee. Kaplan-Meier and Cox proportional hazards techniques were used to estimate incidence and relative risks of PUBs in an intention-to-treat analysis. RESULTS: Patients assigned to rofecoxib had a higher incidence of confirmed PUBs than those randomized to placebo (.88 vs .18 events per 100 patient-years; relative risk, 4.9; 95% confidence interval, 1.98-14.54). The incidence of confirmed complicated PUBs (ulcer perforation, obstruction, or bleeds) was low, but was numerically higher in the rofecoxib than in the placebo group (.23 vs .06 events per 100 patient-years; relative risk, 3.8; 95% confidence interval, .72-37.46; P = .14). Rofecoxib increased the incidence of confirmed PUBs vs placebo in both low-dose aspirin users and nonusers. CONCLUSIONS: Among patients with a history of colorectal adenomas, the long-term use of 25 mg/day of rofecoxib was associated with an increased risk of clinically relevant upper gastrointestinal events when compared with placebo. 相似文献
35.
36.
37.
Journal of Molecular Medicine - Die Erfahrungen über die Behandlung von Leukämien, insbesondere ohronischer Myelosen mit Urethan werden als Grundlage zu Betrachtungen über seine... 相似文献
38.
K. Rintelen Schembra Schoen Hans Hanke Fetscher A. Beutel Arthur Hintze Stotz Hansen Stürmer K. H. Kiefer P. Werner 《Journal of cancer research and clinical oncology》1944,54(5-6):194-200
Ohne Zusammenfassung 相似文献
39.
Ohne Zusammenfassung 相似文献
40.